Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report

ABSTRACT Introduction: Posterior reversible leukoencephalopathy syndrome (PRES) was first described by Hinchey in 1996. The syndrome is characterized by altered level of consciousness, headache, visual changes, and seizures associated with a vasogenic edema of the white matter that occurs predominantly in the occipital and parietal lobes. Imaging tests such as computed tomography (CT) and especially magnetic resonance imaging (MRI) support the diagnosis. Case Report: We report a case of a 48-year-old female patient who underwent a deceased donor kidney transplant and received tacrolimus as a part of the immunosuppressive regimen. Five weeks after transplantation she was admitted to the emergency due to sudden onset of confusion, disorientation, visual disturbances, and major headache. PRES was suspected and the diagnosis confirmed by brain MRI. Tacrolimus was withdrawn and rapid improvement of the neurological signs occurred leading to the conclusion that this drug triggered the syndrome. Conclusion: PRES is an unusual complication after organ transplantation and should be considered in the appropriate clinical setting. Physicians must be aware of this condition in order to provide early detection and appropriate treatment since delay in removing the cause may lead to permanent sequelae.

Saved in:
Bibliographic Details
Main Authors: Davi,Carla Beatriz, Moraes,Bruna Pinheiro de, Lichtenfels,Bruno Fontes, Castro Filho,João Batista Saldanha de, Portal,Marcelle Maria, Montenegro,Rosangela Munhoz, Manfro,Roberto Ceratti
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Nefrologia 2018
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018000100091
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0101-28002018000100091
record_format ojs
spelling oai:scielo:S0101-280020180001000912018-05-11Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case reportDavi,Carla BeatrizMoraes,Bruna Pinheiro deLichtenfels,Bruno FontesCastro Filho,João Batista Saldanha dePortal,Marcelle MariaMontenegro,Rosangela MunhozManfro,Roberto Ceratti Posterior Leukoencephalopathy Syndrome Kidney Transplantation Tacrolimus ABSTRACT Introduction: Posterior reversible leukoencephalopathy syndrome (PRES) was first described by Hinchey in 1996. The syndrome is characterized by altered level of consciousness, headache, visual changes, and seizures associated with a vasogenic edema of the white matter that occurs predominantly in the occipital and parietal lobes. Imaging tests such as computed tomography (CT) and especially magnetic resonance imaging (MRI) support the diagnosis. Case Report: We report a case of a 48-year-old female patient who underwent a deceased donor kidney transplant and received tacrolimus as a part of the immunosuppressive regimen. Five weeks after transplantation she was admitted to the emergency due to sudden onset of confusion, disorientation, visual disturbances, and major headache. PRES was suspected and the diagnosis confirmed by brain MRI. Tacrolimus was withdrawn and rapid improvement of the neurological signs occurred leading to the conclusion that this drug triggered the syndrome. Conclusion: PRES is an unusual complication after organ transplantation and should be considered in the appropriate clinical setting. Physicians must be aware of this condition in order to provide early detection and appropriate treatment since delay in removing the cause may lead to permanent sequelae.info:eu-repo/semantics/openAccessSociedade Brasileira de NefrologiaBrazilian Journal of Nephrology v.40 n.1 20182018-03-01info:eu-repo/semantics/reporttext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018000100091en10.1590/1678-4685-jbn-3825
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Davi,Carla Beatriz
Moraes,Bruna Pinheiro de
Lichtenfels,Bruno Fontes
Castro Filho,João Batista Saldanha de
Portal,Marcelle Maria
Montenegro,Rosangela Munhoz
Manfro,Roberto Ceratti
spellingShingle Davi,Carla Beatriz
Moraes,Bruna Pinheiro de
Lichtenfels,Bruno Fontes
Castro Filho,João Batista Saldanha de
Portal,Marcelle Maria
Montenegro,Rosangela Munhoz
Manfro,Roberto Ceratti
Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report
author_facet Davi,Carla Beatriz
Moraes,Bruna Pinheiro de
Lichtenfels,Bruno Fontes
Castro Filho,João Batista Saldanha de
Portal,Marcelle Maria
Montenegro,Rosangela Munhoz
Manfro,Roberto Ceratti
author_sort Davi,Carla Beatriz
title Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report
title_short Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report
title_full Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report
title_fullStr Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report
title_full_unstemmed Posterior reversible leukoencephalopathy syndrome (PRES) after kidney transplantation: a case report
title_sort posterior reversible leukoencephalopathy syndrome (pres) after kidney transplantation: a case report
description ABSTRACT Introduction: Posterior reversible leukoencephalopathy syndrome (PRES) was first described by Hinchey in 1996. The syndrome is characterized by altered level of consciousness, headache, visual changes, and seizures associated with a vasogenic edema of the white matter that occurs predominantly in the occipital and parietal lobes. Imaging tests such as computed tomography (CT) and especially magnetic resonance imaging (MRI) support the diagnosis. Case Report: We report a case of a 48-year-old female patient who underwent a deceased donor kidney transplant and received tacrolimus as a part of the immunosuppressive regimen. Five weeks after transplantation she was admitted to the emergency due to sudden onset of confusion, disorientation, visual disturbances, and major headache. PRES was suspected and the diagnosis confirmed by brain MRI. Tacrolimus was withdrawn and rapid improvement of the neurological signs occurred leading to the conclusion that this drug triggered the syndrome. Conclusion: PRES is an unusual complication after organ transplantation and should be considered in the appropriate clinical setting. Physicians must be aware of this condition in order to provide early detection and appropriate treatment since delay in removing the cause may lead to permanent sequelae.
publisher Sociedade Brasileira de Nefrologia
publishDate 2018
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018000100091
work_keys_str_mv AT davicarlabeatriz posteriorreversibleleukoencephalopathysyndromepresafterkidneytransplantationacasereport
AT moraesbrunapinheirode posteriorreversibleleukoencephalopathysyndromepresafterkidneytransplantationacasereport
AT lichtenfelsbrunofontes posteriorreversibleleukoencephalopathysyndromepresafterkidneytransplantationacasereport
AT castrofilhojoaobatistasaldanhade posteriorreversibleleukoencephalopathysyndromepresafterkidneytransplantationacasereport
AT portalmarcellemaria posteriorreversibleleukoencephalopathysyndromepresafterkidneytransplantationacasereport
AT montenegrorosangelamunhoz posteriorreversibleleukoencephalopathysyndromepresafterkidneytransplantationacasereport
AT manfrorobertoceratti posteriorreversibleleukoencephalopathysyndromepresafterkidneytransplantationacasereport
_version_ 1756392648172634112